SearcharxivSearch

arXiv subjects

Laura Beretta

Publications and source records attributed to Laura Beretta.

4 recordsLinked to original sources

Risk Prediction in Cancer Imaging Using Enriched Radiomics Features

Background: We aim to develop enriched radiomics features that integrate classical structural radiomics with novel functional radiomics derived from liver MRI for diagnosis and risk stratification in liver cancer. The proposed framework leverages enhancement pattern mapping (EPM) images to provide an automated and robust radiomics representation that captures intratumoral heterogeneity through pixel-level functional information. Methods: Pixel-wise EPM data reflecting blood perfusion were extracted from T1-weighted MRI scans. Classical structural radiomics features were extracted via existing software such as PyRadiomics. In addition, empirical quantiles of EPM values over all pixels within the image, and then smoothed using suitable basis. The smoothed quantiles, along with the classical structural quantiles, are used as functional radiomics features for diagnostic classification and tumor grade stratification, using L1-penalized logistic model that automatically downweights the contribution of the irrelevant features. Further, we conducted longitudinal analyses using Bayesian tensor response regression, which enables spatial smoothing and parsimonious modeling of temporally evolving imaging patterns. Results: The enriched radiomics features illustrate higher diagnostic classification performance (AUC=0.96, sensitivity> 0.8) and superior tumor grade stratification accuracy (AUC=0.87, sensitivity=0.8) compared to alternate radiomics features. Moreover, we find that the proportion of lesion pixels with significant reduction in EPM values over time is considerably higher (median = 0.12) in aggressive lesions versus stable or mildly aggressive lesions (median = 0.025). Conclusion: The enriched novel radiomics features can potentially replace classical radiomics analysis and be used for imaging biomarkers in cross-sectional and in longitudinal cancer imaging studies.

stat.AP

Dimensionality Reduction and Nearest Neighbors for Improving Out-of-Distribution Detection in Medical Image Segmentation

Clinically deployed deep learning-based segmentation models are known to fail on data outside of their training distributions. While clinicians review the segmentations, these models tend to perform well in most instances, which could exacerbate automation bias. Therefore, detecting out-of-distribution images at inference is critical to warn the clinicians that the model likely failed. This work applied the Mahalanobis distance (MD) post hoc to the bottleneck features of four Swin UNETR and nnU-net models that segmented the liver on T1-weighted magnetic resonance imaging and computed tomography. By reducing the dimensions of the bottleneck features with either principal component analysis or uniform manifold approximation and projection, images the models failed on were detected with high performance and minimal computational load. In addition, this work explored a non-parametric alternative to the MD, a k-th nearest neighbors distance (KNN). KNN drastically improved scalability and performance over MD when both were applied to raw and average-pooled bottleneck features.

cs.CV

Heterogeneous Image-based Classification Using Distributional Data Analysis

Diagnostic imaging has gained prominence as potential biomarkers for early detection and diagnosis in a diverse array of disorders including cancer. However, existing methods routinely face challenges arising from various factors such as image heterogeneity. We develop a novel imaging-based distributional data analysis (DDA) approach that incorporates the probability (quantile) distribution of the pixel-level features as covariates. The proposed approach uses a smoothed quantile distribution (via a suitable basis representation) as functional predictors in a scalar-on-functional quantile regression model. Some distinctive features of the proposed approach include the ability to: (i) account for heterogeneity within the image; (ii) incorporate granular information spanning the entire distribution; and (iii) tackle variability in image sizes for unregistered images in cancer applications. Our primary goal is risk prediction in Hepatocellular carcinoma that is achieved via predicting the change in tumor grades at post-diagnostic visits using pre-diagnostic enhancement pattern mapping (EPM) images of the liver. Along the way, the proposed DDA approach is also used for case versus control diagnosis and risk stratification objectives. Our analysis reveals that when coupled with global structural radiomics features derived from the corresponding T1-MRI scans, the proposed smoothed quantile distributions derived from EPM images showed considerable improvements in sensitivity and comparable specificity in contrast to classification based on routinely used summary measures that do not account for image heterogeneity. Given that there are limited predictive modeling approaches based on heterogeneous images in cancer, the proposed method is expected to provide considerable advantages in image-based early detection and risk prediction.

stat.AP

Enhancement Pattern Mapping for Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Background and Aims: Limited methods exist to accurately characterize risk of malignant progression of liver lesions in patients undergoing surveillance for hepatocellular carcinoma (HCC). Enhancement pattern mapping (EPM) measures voxel-based root mean square deviation (RMSD) and improves the contrast-to-noise ratio (CNR) of liver lesions on standard of care imaging. This study investigates the utilization of EPM to differentiate between HCC versus benign cirrhotic tissue. Methods: Patients with liver cirrhosis undergoing MRI surveillance at a single, tertiary-care hospital were studied prospectively. Controls (n=99) were patients without lesions during surveillance or progression to HCC. Cases (n=48) were defined as patients with LI-RADS 3 and 4 lesions who developed HCC within the study period. RMSD measured with EPM was compared to the signal from MRI arterial and portovenous (PV) phases. EPM signals of liver parenchyma between cases and controls were quantitatively validated on an independent patient set using cross validation. Results: With EPM, RMSD of 0.37 was identified as a quantitative cutoff for distinguishing lesions that progress to HCC from background parenchyma on pre-diagnostic scans with an area under the curve (AUC) of 0.83 (CI: 0.73-0.94) and a sensitivity, specificity, and accuracy of 0.65, 0.97, and 0.89, respectively. At the time of diagnostic scans, a sensitivity, specificity, and accuracy of 0.79, 0.93, and 0.88 was achieved with an AUC of 0.89 (CI: 0.82-0.96). EPM RMSD signals of background parenchyma in cases and controls were similar (case EPM: 0.22 +/- 0.08, control EPM: 0.22 +/- 0.09, p=0.8). Conclusions: EPM differentiates between HCC and non-cancerous parenchyma in a surveillance population and may aid in early detection of HCC. Future directions involve applying EPM for risk stratification of indeterminate lesions.

physics.med-ph